ÂÜÀòÂÒÂ×

Kylie Balotin is a Scientist I specializing in Target Validation at Verge Genomics, where responsibilities include culturing various human cell types to investigate pathways related to Parkinson's disease and conducting wet lab assays. Previous experience as a Doctoral Student at Vanderbilt University involved developing bio-functionalized hydrogels and 3D human neural tissue models for neurodegenerative disease research, alongside roles as a teaching assistant. Kylie's research contributions span multiple institutions, including workshops on bioreactor programming and earlier work investigating glioma cell behavior. Kylie holds a PhD in Bioengineering and Biomedical Engineering from Vanderbilt University and a BS from Rice University, complemented by diverse research experiences in biomedicine and bioengineering.